🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)My year on Mounjaro — July 2024 Page 7

My year on Mounjaro — July 2024

oliver_london Tue, Dec 17, 2024 at 12:11 PM 48 replies 2,414 viewsPage 7 of 10
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Mar 23, 2025 at 11:36 PM#31
DataDave said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Bookmarking. The distinction being drawn above is the one nobody else makes.

Last edited: Mar 24, 2025 at 2:36 AM
40 13Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 37 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Mar 31, 2025 at 3:34 AM#32

Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Last edited: Mar 31, 2025 at 8:34 AM
41 14Dr.NateNeph, PharmD_Rodriguez, julia.endo and 38 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Apr 7, 2025 at 7:28 AM#33
andrew_nyc said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Second this.

42 15cory_ATX, lori_vegas, Dr.PulmRoch and 39 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Apr 14, 2025 at 11:18 AM#34
andrew_nyc said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

There is a second half to this that has not been said yet. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

Happy to go further on any of that.

43 16TomFromTexas, mike.trainer_LA, sarah_nash92 and 40 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Apr 21, 2025 at 3:03 PM#35

Adding the numbers, since they settle part of this. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Last edited: Apr 21, 2025 at 6:03 PM
44 17LabKate, kate.chem, DataDave and 41 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register